Primary Sjören's syndrome with central nervous system involvement can clinically mimic multiple sclerosis (MS). However, SS and MS may coexist. We report here a case of a 48-year-old woman affected by relapsing-remitting MS, good responder to interferon (IFN)-beta 1a, developing sicca complex after 29 years from MS onset. At the age of 48, after 5 years successful treatment with i.m. IFN-beta 1a, xerophtalmia and xerostomia with dysphagia occurred. Autoantibody screening for connective tissue diseases, including anti-ENA, was negative. Schirmer's test showed reduced lacrimal gland function and a minor salivary gland biopsy showed chronic inflammatory infiltration with fibrosis, acinar atrophy and ductal ectasia. According to clinical and pa...
Recombinant interferon (IFN) β-1b was approved by the US Food and Drug Administration as the first d...
Copyright © 2011 Kurosh Gharagozli et al. This is an open access article distributed under the Creat...
Background: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease, characterized by mono...
Primary Sjören's syndrome with central nervous system involvement can clinically mimic multiple scle...
Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common ...
AbstractCoexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to...
Preliminary studies have evaluated the effects of interferonβ formulations in the treatment of chron...
Background: Multiple sclerosis (MS) like disease may be a feature of central nervous system (CNS) in...
Multiple sclerosis (MS) is a chronic disease of the central nervous system, characterized by focal i...
Sjögren syndrome (SS) is a chronic, inflammatory, autoimmune disease. It emerges as a dry mouth and ...
Autoimmune side effects, namely autoantibody (autoAb) occurrence and thyroid function alteration, ha...
Interferon (IFN)-beta has become a widespread therapy for multiple sclerosis. As already reported fo...
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) has only rarely been reported in pat...
Abstract Background Susac syndrome (SS) is characterized by the triad of encephalopathy, branch reti...
Background: Neutralizing anti-drug antibodies (NAbs) to interferon beta (IFNβ) develop in up to 47% ...
Recombinant interferon (IFN) β-1b was approved by the US Food and Drug Administration as the first d...
Copyright © 2011 Kurosh Gharagozli et al. This is an open access article distributed under the Creat...
Background: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease, characterized by mono...
Primary Sjören's syndrome with central nervous system involvement can clinically mimic multiple scle...
Coexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to common ...
AbstractCoexistence of multiple sclerosis (MS) with other autoimmune diseases has been attributed to...
Preliminary studies have evaluated the effects of interferonβ formulations in the treatment of chron...
Background: Multiple sclerosis (MS) like disease may be a feature of central nervous system (CNS) in...
Multiple sclerosis (MS) is a chronic disease of the central nervous system, characterized by focal i...
Sjögren syndrome (SS) is a chronic, inflammatory, autoimmune disease. It emerges as a dry mouth and ...
Autoimmune side effects, namely autoantibody (autoAb) occurrence and thyroid function alteration, ha...
Interferon (IFN)-beta has become a widespread therapy for multiple sclerosis. As already reported fo...
BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) has only rarely been reported in pat...
Abstract Background Susac syndrome (SS) is characterized by the triad of encephalopathy, branch reti...
Background: Neutralizing anti-drug antibodies (NAbs) to interferon beta (IFNβ) develop in up to 47% ...
Recombinant interferon (IFN) β-1b was approved by the US Food and Drug Administration as the first d...
Copyright © 2011 Kurosh Gharagozli et al. This is an open access article distributed under the Creat...
Background: Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease, characterized by mono...